MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Use of bupivacaine in the evaluation of acute secondary cervical dystonia (CD)

JR. Chai, S. Bansal, C. Li, M. Jog (London, Canada)

Meeting: 2022 International Congress

Abstract Number: 525

Keywords: Botulinum toxin: Clinical applications: dystonia, Dystonia: Treatment, Pain

Category: Dystonia: Clinical Trials and Therapy

Objective: To highlight the potential use of bupivacaine/analgesics in assessing cervical dystonia, where disabling local pain can be a confounder and limits clinical examination.

Background: Significant pain is common in CD. Voluntary or involuntary posturing may occur to relieve this pain, complicating underlying CD pattern  thereby impacting assessment and determination of botulinum toxin dose. Using local analgesics such as bupivacaine to relieve this pain acutely during assessment may address this issue.

Method: To illustrate this, we describe a patient where the use of local bupivacaine injection aided in confirming acute post-stroke torticollis and formulation of an effective injection pattern.

Results: A previously healthy 41-year-old female presented after a thunderclap headache and was found to have a large right frontotemporal intracerebral hemorrhage with superimposed diffuse subarachnoid hemorrhage, secondary to a ruptured right M2 aneurysm. Clinically, the patient had left hemiparesis. The patient has subsequently undergone emergent right craniotomy for evacuation of intracranial hemorrhage and clipping of aneurysm.
The patient was extubated on postoperative day 3. Significant pain was reported over the patient’s neck and shoulder, with her neck rotated towards the left, not correctable with passive maneuvers due to complaints of worsening pain. Her pain was not amendable to oral analgesics, and post-stroke rehabilitation was suspended.
Examination showed an extreme leftward torticollis. The range of motion (ROM) was significantly limited and accompanied by worsening pain in the right anterior neck. Palpation revealed a tense right sternocleidomastoid (SCM) and significant muscular tenderness over the right SCM, levator and trapezius muscles. CT scan of her cervical spine ruled out any causative etiology. Bupivacaine was injected intramuscularly in the right SCM, levator, and trapezius muscles, producing significant pain relief. Despite 10-15 degree improvement in the active ROM of her neck, there was a persistent, significant leftward turn suggesting dystonia. Botulinum toxin injection in the right SCM, levator, and trapezius substantially improved her ROM towards the midline.

Conclusion: Our case highlights the role of local analgesics as a valuable tool in evaluating secondary cervical dystonia complicated by pain.

To cite this abstract in AMA style:

JR. Chai, S. Bansal, C. Li, M. Jog. Use of bupivacaine in the evaluation of acute secondary cervical dystonia (CD) [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/use-of-bupivacaine-in-the-evaluation-of-acute-secondary-cervical-dystonia-cd/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/use-of-bupivacaine-in-the-evaluation-of-acute-secondary-cervical-dystonia-cd/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley